Geode Capital Management’s Akcea Therapeutics, Inc. Common Stock AKCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-317,000
| Closed | -$5.75M | – | 4351 |
|
|
2020
Q3 | $5.75M | Sell |
317,000
-13,979
| -4% | -$254K | ﹤0.01% | 2309 |
|
|
2020
Q2 | $4.53M | Buy |
330,979
+58,959
| +22% | +$808K | ﹤0.01% | 2390 |
|
|
2020
Q1 | $3.89M | Buy |
272,020
+20,629
| +8% | +$295K | ﹤0.01% | 2284 |
|
|
2019
Q4 | $4.26M | Sell |
251,391
-5,920
| -2% | -$100K | ﹤0.01% | 2556 |
|
|
2019
Q3 | $3.96M | Buy |
257,311
+10,991
| +4% | +$169K | ﹤0.01% | 2521 |
|
|
2019
Q2 | $5.78M | Buy |
246,320
+5,523
| +2% | +$130K | ﹤0.01% | 2296 |
|
|
2019
Q1 | $6.82M | Buy |
240,797
+15,763
| +7% | +$447K | ﹤0.01% | 2143 |
|
|
2018
Q4 | $6.78M | Buy |
225,034
+15,950
| +8% | +$481K | ﹤0.01% | 2035 |
|
|
2018
Q3 | $7.32M | Buy |
209,084
+5,953
| +3% | +$208K | ﹤0.01% | 2130 |
|
|
2018
Q2 | $4.82M | Sell |
203,131
-4,008
| -2% | -$95K | ﹤0.01% | 2345 |
|
|
2018
Q1 | $5.3M | Buy |
207,139
+2,599
| +1% | +$66.6K | ﹤0.01% | 2201 |
|
|
2017
Q4 | $3.55M | Buy |
204,540
+3,147
| +2% | +$54.6K | ﹤0.01% | 2421 |
|
|
2017
Q3 | $5.57M | Buy |
+201,393
| New | +$5.57M | ﹤0.01% | 2139 |
|